Covid: Paxlovid receives definitive registration from Anvisa – 01/06/2024 – Health
Pfizer's Covid drug, Paxlovid, received definitive registration from Anvisa (National Health Surveillance Agency) on December 29th. Previously, its use had...
Pfizer's Covid drug, Paxlovid, received definitive registration from Anvisa (National Health Surveillance Agency) on December 29th. Previously, its use had...
A new study has pointed out the risks associated with developing symptoms of the so-called long Covid. Among them are...
The SBI (Brazilian Society of Infectious Diseases) presented, on the night of this Friday (3), the main results of a...
Brazilian researchers are waiting for an opinion from Anvisa (National Health Surveillance Agency) to start clinical trials of a new...